HYDERABAD, India, Aug. 08, 2025 (GLOBE NEWSWIRE) — Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research, Development and Manufacturing Organization (CRDMO) announced its financial results for the first quarter of Fiscal year 2026.
Financial Performance:
| Particulars (₹ crores) | Q1FY26 | Q1FY25 | YoY% | FY25 | FY24 | YoY% |
| Revenue from Operations | 496 | 280 | 77% | 1695 | 1,465 | 16% |
| EBITDA | 125 | 31 | 303% | 425 | 300 | 42% |
| EBITDA Margin% | 25% | 11% | – | 25% | 20% | – |